Stanford University - Stanford Cancer Institute — Stanford, California

Stanford University - Stanford Cancer Institute is a clinical research site located in Stanford, California, United States 94305.

Crixeo Clinical Trials Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford University - Stanford Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer.

Sponsors: Revolution Medicines, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Stanford

Browse all research sites in California · View every site in Stanford

• Stanford University School of Med /ID# 236922
• Stanford Hospitals and Clinics
• Stanford University School of Med /ID# 242809
• Stanford University School of Medicine; Stanford Hospital Pharmacy
• Stanford hospital & Clinics; Investigational Drug Services
• Stanford University Medical School
• Stanford University Medical Center Stanford Comprehensive Cancer Center
• Stanford Medical Center and Lucile Packard Children's Hospital
• Stanfor University
• Stanford University Department of Pediatric Endocrinology
• Stanford University Medical Center Stanford
• University of Stanford Medical Center

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University - Stanford Cancer Institute?

Stanford University - Stanford Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University - Stanford Cancer Institute conducted?

Stanford University - Stanford Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer.

Is Stanford University - Stanford Cancer Institute accredited by Crixeo Clinical Trials?

Stanford University - Stanford Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University - Stanford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.